Loughborough is home to a new, world class science and technology park located on a former AstraZeneca research and development site. In 2012, the site was acquired by a privately owned organisation, which has appointed Carl Edwards to manage the day-to-day operation and attract tenants from the pharmaceuticals industry, life sciences, new technology, R&D, academia and the public sector to the high-quality laboratory and office space on the site.
The aim is to create a flourishing R&D environment while establishing good links to local universities and the UK’s National Health Service (NHS) to attract new graduates to the companies on site and create innovative research collaborations. The hope is that ideas will come to life and thrive on the Charnwood Biomedical Campus, and that it will be a unique and exciting place to work that will add value and opportunity to the local economy.
The 70-acre site will provide 450,000ft2 of first class facilities, including multi-purpose, specialist laboratories, cleanrooms, a pilot-scale manufacturing plant, offices, warehousing and parking for 1,500 vehicles.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.
Subscribe now Already a subscriber? Sign in here.